These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26684823)

  • 1. Dosing antiretroviral medication when crossing time zones: a review.
    Lewis JM; Volny-Anne A; Waitt C; Boffito M; Khoo S
    AIDS; 2016 Jan; 30(2):267-71. PubMed ID: 26684823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral drug treatment of CNS HIV-1 infection.
    Yilmaz A; Price RW; Gisslén M
    J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring.
    Slish JC; Catanzaro LM; Ma Q; Okusanya OO; Demeter L; Albrecht M; Morse GD
    Curr Pharm Des; 2006; 12(9):1129-45. PubMed ID: 16515491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens.
    Kala S; Watson B; Zhang JG; Papp E; Guzman Lenis M; Dennehy M; Cameron DW; Harrigan PR; Serghides L
    Antiviral Res; 2018 Nov; 159():45-54. PubMed ID: 30236532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily therapies.
    Carey D
    J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
    Dickinson L; Khoo S; Back D
    Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel patterns and risk behaviour of HIV-positive people travelling internationally.
    Salit IE; Sano M; Boggild AK; Kain KC
    CMAJ; 2005 Mar; 172(7):884-8. PubMed ID: 15795409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to: Pharmacokinetic and Pharmacodynamic Drug Interactions between Antiretrovirals and Oral Contraceptives.
    Atrio JM
    Clin Pharmacokinet; 2015 May; 54(5):563-4. PubMed ID: 25701379
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update and review of antiretroviral therapy.
    Piacenti FJ
    Pharmacotherapy; 2006 Aug; 26(8):1111-33. PubMed ID: 16863488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 13. Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents.
    Winston A; Garvey L; Sabin CA
    AIDS; 2011 Apr; 25(7):1014-5. PubMed ID: 21487256
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with antiretrovirals.
    Catanzaro LM; Slish JC; DiCenzo R; Morse GD
    Curr HIV/AIDS Rep; 2004 Jun; 1(2):89-96. PubMed ID: 16091228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.
    Nwokolo N; Boffito M
    Clin Pharmacokinet; 2015 May; 54(5):565. PubMed ID: 25732266
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapy.
    Boffito M
    New Microbiol; 2007 Jul; 30(3):346-9. PubMed ID: 17802923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-drug interactions involving new antiretroviral drugs and drug classes.
    Soodalter J; Sousa M; Boffito M
    Curr Opin Infect Dis; 2009 Feb; 22(1):18-27. PubMed ID: 19532077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents.
    Jiménez-Montero B; Beceiro J; de José-Gómez MI; González-Tomé MI; Gurbindo-Gutierrez D; Martínez-Pérez J; Mellado-Peña MJ; Navarro-Gómez ML; Roa-Francia MA; Rojo-Conejo P; Saavedra-Lozano J; Jiménez de Ory S; Ramos-Amador JT;
    Pediatr Infect Dis J; 2014 Oct; 33(10):1052-4. PubMed ID: 24747153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.